Implementation of a medicine management plan (MMP) to reduce medication-related harm (MRH) in older people post-hospital discharge

a randomised controlled trial

Journal Article (2022)
Author(s)

Khalid Ali (University of Sussex)

Ekow A. Mensah (University of Sussex)

Eugene Ace McDermott (University of Sussex)

Frances A. Kirkham (University of Sussex)

Jennifer Stevenson (King’s College London)

Victoria Hamer (Kingston University)

Nikesh Parekh (University of Sussex)

Rebekah Schiff (St. Tomas Hospital, London)

Tischa Van Der Cammen (TU Delft - Industrial Design Engineering, Erasmus MC)

undefined More Authors (External organisation)

Research Group
Human Factors
DOI related publication
https://doi.org/10.1186/s12877-022-03555-w Final published version
More Info
expand_more
Publication Year
2022
Language
English
Research Group
Human Factors
Issue number
1
Volume number
22
Article number
850
Downloads counter
332
Collections
Institutional Repository
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Background: Medication-related harm (MRH) is an escalating global challenge especially among older adults. The period following hospital discharge carries high-risk for MRH due to medication discrepancies, limited patient/carer education and support, and poor communication between hospital and community professionals. Discharge Medical Service (DMS), a newly introduced NHS scheme, aims to reduce post-discharge MRH through an electronic communication between hospital and community pharmacists. Our study team has previously developed a risk-prediction tool (RPT) for MRH in the 8-weeks period post discharge from a UK hospital cohort of 1280 patients. In this study, we aim to find out if a Medicines Management Plan (MMP) linked to the DMS is more effective than the DMS alone in reducing rates of MRH. Method: Using a randomized control trial design, 682 older adults ≥ 65 years due to be discharged from hospital will be recruited from 4 sites. Participants will be randomized to an intervention arm (individualised medicine management plan (MMP) plus DMS) or a control arm (DMS only) using a 1:1 ratio stratification. Baseline data will include patients’ clinical and social demographics, and admission and discharge medications. At 8-weeks post-discharge, a telephone interview and review of GP records by the study pharmacist will verify MRH in both arms. An economic and process evaluation will assess the cost and acceptability of the study methods. Data analysis: Univariate analysis will be done for baseline variables comparing the intervention and control arms. A multivariate logistic regression will be done incorporating these variables. Economic evaluation will compare the cost-of-service use among the study arms and modelled to provide national estimates. Qualitative data from focus-group interviews will explore practitioners’ understanding, and acceptance of the MMP, DMS and the RPT. Conclusion: This study will inform the use of an objective, validated RPT for MRH among older adults after hospital discharge, and provide a clinical, economic, and service evaluation of a specific medicines management plan alongside the DMS in the National Health Service (UK).